Home/Companies/Johnson & Johnson

Johnson & Johnson (JNJ) : key figures and financial history

Historical revenue, net income, net margin and earnings per share of Johnson & Johnson, year by year from 2010 to 2025. Market data, amounts in US dollars.

Sector
Health
Country / place
🇺🇸 United States
Market cap
687,89 billion $
Price at 13/11/2026
285,75 $

Year-by-year financial history

Revenue, net income, net margin, earnings per share (EPS) and revenue growth. Amounts in USD.

YearRevenueNet incomeNet marginBPARevenue growth
201061,59 billion $13,33 billion $21,6 %4,86 $n/d
201165,03 billion $9,67 billion $14,9 %3,54 $+5,6 %
201267,22 billion $10,85 billion $16,1 %3,91 $+3,4 %
201371,31 billion $13,83 billion $19,4 %4,90 $+6,1 %
201474,33 billion $16,32 billion $22,0 %5,86 $+4,2 %
201570,07 billion $15,41 billion $22,0 %5,57 $-5,7 %
201671,89 billion $16,54 billion $23,0 %6,08 $+2,6 %
201776,45 billion $1,30 billion $1,7 %0,48 $+6,3 %
201881,58 billion $15,30 billion $18,8 %5,75 $+6,7 %
201982,06 billion $15,12 billion $18,4 %5,74 $+0,6 %
202082,58 billion $14,71 billion $17,8 %5,59 $+0,6 %
202178,74 billion $20,88 billion $26,5 %7,93 $-4,7 %
202279,99 billion $17,94 billion $22,4 %6,83 $+1,6 %
202385,16 billion $35,15 billion $41,3 %13,88 $+6,5 %
202488,82 billion $14,07 billion $15,8 %5,84 $+4,3 %
202594,19 billion $26,80 billion $28,5 %11,03 $+6,0 %

Revenue and net income evolution

Graphical representation of annual amounts (in USD).

20102012201420162018202020222024
RevenueNet income

Current ratios

Valuation and profitability; price ratios calculated based on the price of 13/11/2026.

P/E
26,63
PEG
0,21
EV/EBITDA
12,97
ROE
32,9 %
Debt / EPS
0,59
Yield
2,46 %
Methodology. The amounts (turnover, net income) are expressed in US dollars, converted at the 15/11/2026 exchange rate; the share price is displayed in its trading currency; ratios are currency-neutral. Revenue growth is calculated from one year to the next based on published real values. No value is estimated: a missing data point is noted as "n/d" or is not displayed. This information does not constitute investment advice. Share price and market capitalization as of 13/11/2026.